Skip to main content
Fig. 1 | Neurological Research and Practice

Fig. 1

From: Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban

Fig. 1

Scatter plots visualizing the correlation of (a) laboratory-based calibrated anti-Xa activity and (b to e) the results of all four Hemochron™ Signature Elite point-of-care test system-based coagulation assays with edoxaban plasma concentrations determined by mass spectrometry. HC-INR, HC-ACT+, HC-ACT-LR, HC-aPTT = Hemochron™ Signature Elite point-of-care test system-based international normalized ratio, activated clotting time, and activated partial thromboplastin time

Back to article page

Neurological Research and Practice

ISSN: 2524-3489

Contact us